| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
vTv Therapeutics Inc. is a biopharmaceutical company in the clinical development stage, primarily focused on creating orally administered treatments, with a significant emphasis on diabetes. Its pipeline features lead candidates such as TTP399, an oral, small-molecule, liver-specific glucokinase activator targeting Type 1 diabetes. Another key investigational drug is HPP737, an oral phosphodiesterase type 4 (PDE4) inhibitor that does not cross the blood-brain barrier (non-CNS penetrant), designed to treat inflammatory conditions and psoriasis. …
Over the last 12 months, insiders at vTv Therapeutics Inc. have bought $0 and sold $0 worth of vTv Therapeutics Inc. stock.
On average, over the past 5 years, insiders at vTv Therapeutics Inc. have bought $67,277 and sold $100,050 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 1,844 shares for transaction amount of $31,269 was made by SEKHRI PAUL J (Pres, CEO and Exec Chairperson) on 2024‑11‑18.
| 2024-11-18 | SEKHRI PAUL J | Pres, CEO and Exec Chairperson | 1,844 0.058% | $16.96 | $31,269 | +0.77% | ||
| 2024-11-15 | SEKHRI PAUL J | Pres, CEO and Exec Chairperson | 3,156 0.1377% | $16.65 | $52,543 | -2.24% | ||
| 2022-11-29 | FRY JOHN A | director | 40,461 0.0852% | $0.83 | $33,773 | -12.01% | ||
| 2022-11-28 | FRY JOHN A | director | 20,539 0.0431% | $0.83 | $16,969 | -11.38% | ||
| 2021-12-20 | Sale | PERELMAN RONALD O | director | 87,000 0.154% | $1.15 | $100,050 | -26.54% | |
| 2021-02-26 | Nelson Rich S. | director | 60,000 0.1142% | $2.86 | $171,600 | -31.58% | ||
| 2021-02-26 | KOZLOV HERSH | director | 10,000 0.0182% | $2.74 | $27,400 | -31.58% | ||
| 2020-12-17 | PERELMAN RONALD O | director | 625,000 0.9225% | $1.60 | $1M | -2.36% | ||
| 2020-12-10 | PERELMAN RONALD O | director | 625,000 0.893% | $1.60 | $1M | -4.79% | ||
| 2020-11-24 | PERELMAN RONALD O | director | 625,000 1.0514% | $1.60 | $1M | +13.44% | ||
| 2020-05-15 | KOZLOV HERSH | director | 10,000 0.022% | $3.00 | $30,000 | -22.48% | ||
| 2020-05-12 | PERELMAN RONALD O | director | 625,000 0.8555% | $1.60 | $1M | -8.98% | ||
| 2020-02-25 | PERELMAN RONALD O | director | 1.25M 1.438% | $1.60 | $2M | -33.44% | ||
| 2020-01-28 | PERELMAN RONALD O | director | 1.25M 2.1109% | $1.60 | $2M | -2.29% | ||
| 2020-01-07 | PERELMAN RONALD O | director | 1.25M 2.5998% | $1.60 | $2M | +20.34% | ||
| 2019-12-18 | PERELMAN RONALD O | director | 1.37M 4.3437% | $1.46 | $2M | +40.13% | ||
| 2019-11-26 | PERELMAN RONALD O | director | 1.37M 4.4914% | $1.46 | $2M | +42.86% | ||
| 2019-11-12 | PERELMAN RONALD O | director | 1.37M 4.3437% | $1.46 | $2M | +38.16% | ||
| 2019-10-24 | PERELMAN RONALD O | director | 1.37M 4.2053% | $1.46 | $2M | +33.76% | ||
| 2019-09-26 | PERELMAN RONALD O | director | 1.37M 4.3232% | $1.46 | $2M | +45.83% |
| PERELMAN RONALD O | director | 36519212 923.6185% | $860.03M | 61 | 1 | +17.2% |
| SAVAS PAUL G | director | 91781 2.3213% | $2.16M | 16 | 0 | +66.67% |
| FRY JOHN A | director | 61000 1.5428% | $1.44M | 2 | 0 | <0.0001% |
| Nelson Rich S. | director | 50000 1.2646% | $1.18M | 1 | 0 | <0.0001% |
| KOZLOV HERSH | director | 25000 0.6323% | $588,750.00 | 3 | 0 | <0.0001% |
| Spiegel Noel Joseph | director | 6000 0.1517% | $141,300.00 | 2 | 0 | |
| HOWARD RUDY | CFO & Secretary | 5000 0.1265% | $117,750.00 | 1 | 0 | |
| SEKHRI PAUL J | Pres, CEO and Exec Chairperson | 5000 0.1265% | $117,750.00 | 2 | 0 | <0.0001% |
| Cohen Steven Michael | director | 5000 0.1265% | $117,750.00 | 1 | 0 |
$5,552,811 | 165 | 5.84% | $106.2M | |
$1,701,941 | 56 | 17.58% | $93.09M | |
$66,137,559 | 49 | 6.29% | $89.66M | |
vTv Therapeutics Inc. (VTVT) | $77,146,704 | 43 | 13.28% | $93.12M |
$63,049,419 | 31 | 2.87% | $107.27M |
| Increased Positions | 15 | +71.43% | 395,930 | +40.06% |
| Decreased Positions | 6 | -28.57% | 100,587 | -10.18% |
| New Positions | 7 | New | 262,531 | New |
| Sold Out Positions | 3 | Sold Out | 22,820 | Sold Out |
| Total Postitions | 30 | +42.86% | 1M | +29.88% |
| Samsara Biocapital, Llc | $14,829.00 | 9.36% | 374,461 | +167,677 | +81.09% | 2025-09-30 |
| Fmr Llc | $7,638.00 | 4.82% | 192,891 | +14,691 | +8.24% | 2025-09-30 |
| Siren, L.L.C. | $6,455.00 | 4.08% | 163,000 | +163,000 | New | 2025-09-30 |
| Baker Bros. Advisors Lp | $5,873.00 | 3.71% | 148,314 | +51,000 | +52.41% | 2025-09-30 |
| Vanguard Group Inc | $1,861.00 | 1.18% | 46,990 | +3,815 | +8.84% | 2025-09-30 |
| Geode Capital Management, Llc | $606.00 | 0.38% | 15,298 | +2,432 | +18.9% | 2025-09-30 |
| Northern Trust Corp | $557.00 | 0.35% | 14,072 | -1,215 | -7.95% | 2025-09-30 |
| Millennium Management Llc | $512.00 | 0.32% | 12,935 | -2,107 | -14.01% | 2025-09-30 |
| Connective Capital Management, Llc | $385.00 | 0.24% | 9,712 | 0 | 0% | 2025-09-30 |
| Blackrock, Inc. | $195.00 | 0.12% | 4,935 | +108 | +2.24% | 2025-09-30 |